- Home
- PROK vs MLGO Comparison
PROK vs MLGO Comparison
Compare PROK & MLGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- MLGO
- Stock Information
- Founded
- PROK 2015
- MLGO 2018
- Country
- PROK United States
- MLGO China
- Employees
- PROK N/A
- MLGO N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- MLGO EDP Services
- Sector
- PROK Health Care
- MLGO Technology
- Exchange
- PROK Nasdaq
- MLGO Nasdaq
- Market Cap
- PROK 126.8M
- MLGO 139.5M
- IPO Year
- PROK N/A
- MLGO N/A
- Fundamental
- Price
- PROK $0.60
- MLGO $16.92
- Analyst Decision
- PROK Buy
- MLGO
- Analyst Count
- PROK 4
- MLGO 0
- Target Price
- PROK $5.00
- MLGO N/A
- AVG Volume (30 Days)
- PROK 410.9K
- MLGO 33.1M
- Earning Date
- PROK 05-09-2025
- MLGO 04-15-2025
- Dividend Yield
- PROK N/A
- MLGO N/A
- EPS Growth
- PROK N/A
- MLGO N/A
- EPS
- PROK N/A
- MLGO N/A
- Revenue
- PROK $76,000.00
- MLGO $83,504,125.00
- Revenue This Year
- PROK N/A
- MLGO N/A
- Revenue Next Year
- PROK N/A
- MLGO N/A
- P/E Ratio
- PROK N/A
- MLGO N/A
- Revenue Growth
- PROK N/A
- MLGO 643.57
- 52 Week Low
- PROK $0.68
- MLGO $1.11
- 52 Week High
- PROK $4.44
- MLGO $509.60
- Technical
- Relative Strength Index (RSI)
- PROK 21.04
- MLGO 64.86
- Support Level
- PROK $0.87
- MLGO $15.40
- Resistance Level
- PROK $1.00
- MLGO $32.40
- Average True Range (ATR)
- PROK 0.10
- MLGO 5.72
- MACD
- PROK -0.01
- MLGO 0.91
- Stochastic Oscillator
- PROK 3.98
- MLGO 51.37
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About MLGO MicroAlgo Inc.
MicroAlgo Inc is divided into two segments Central processing algorithm services & Intelligent chips and services. The majority is from the Central processing algorithm services. which refer to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.